{"id":"https://openalex.org/W4253472549","doi":"https://doi.org/10.1093/neuonc/noz211","title":"Highlights from the Literature","display_name":"Highlights from the Literature","publication_year":2019,"publication_date":"2019-10-25","ids":{"openalex":"https://openalex.org/W4253472549","doi":"https://doi.org/10.1093/neuonc/noz211"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noz211","doi":"https://doi.org/10.1093/neuonc/noz211","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noz211","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/12/1495/31557280/noz211.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/12/1495/31557280/noz211.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076042525","display_name":"Benjamin W. Purow","orcid":"https://orcid.org/0000-0001-7372-6062","observed_orcids":["https://orcid.org/0000-0001-7372-6062"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Purow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084589096","display_name":"Alain Charest","orcid":"https://orcid.org/0000-0002-1548-6950","observed_orcids":["https://orcid.org/0000-0002-1548-6950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alain Charest","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082835319","display_name":"Elizabeth Robins Gerstner","orcid":"https://orcid.org/0000-0003-2382-3838","observed_orcids":["https://orcid.org/0000-0003-2382-3838"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Gerstner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048627921","display_name":"Monika E. Hegi","orcid":"https://orcid.org/0000-0003-0855-6495","observed_orcids":["https://orcid.org/0000-0003-0855-6495"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monika Hegi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5063290790","display_name":"Kenneth Aldape","orcid":"https://orcid.org/0000-0001-5119-7550","observed_orcids":["https://orcid.org/0000-0001-5119-7550"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth Aldape","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.3711761,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"12","first_page":"1495","last_page":"1497"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.9442999958992004,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.9442999958992004,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.023399999365210533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer-brain-metastases","display_name":"breast cancer brain metastasis","score":0.9850000143051147},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.9309999942779541},{"id":"https://openalex.org/keywords/nr2b-subunit","display_name":"NR2B subunit","score":0.9850000143051147},{"id":"https://openalex.org/keywords/glutamate-receptors","display_name":"glutamate receptors","score":0.6850000023841858},{"id":"https://openalex.org/keywords/glutamatergic-synapses","display_name":"glutamatergic synapses","score":0.8500000238418579},{"id":"https://openalex.org/keywords/basal-like-breast-cancer","display_name":"basal-like breast cancer","score":0.7749999761581421},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":0.722000002861023},{"id":"https://openalex.org/keywords/circadian-clock","display_name":"circadian clock","score":0.8140000104904175},{"id":"https://openalex.org/keywords/clock-genes","display_name":"clock genes","score":0.640999972820282},{"id":"https://openalex.org/keywords/breast-cancer-recurrence","display_name":"breast cancer recurrence","score":0.37400001287460327},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.656000018119812},{"id":"https://openalex.org/keywords/stereotactic-radiosurgery","display_name":"stereotactic radiosurgery","score":0.8560000061988831}],"concepts":[{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.2828708589076996}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noz211","doi":"https://doi.org/10.1093/neuonc/noz211","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noz211","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/12/1495/31557280/noz211.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6917406","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6917406","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noz211","doi":"https://doi.org/10.1093/neuonc/noz211","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noz211","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/12/1495/31557280/noz211.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4253472549.pdf","grobid_xml":"https://content.openalex.org/works/W4253472549.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2973455289","https://openalex.org/W4388590028","https://openalex.org/W4248177892","https://openalex.org/W4210501061","https://openalex.org/W7155187504","https://openalex.org/W2066030073","https://openalex.org/W2460179769","https://openalex.org/W4387138184","https://openalex.org/W4232343395","https://openalex.org/W4412363103"],"abstract_inverted_index":{"Central":[0],"nervous":[1],"system":[2],"metastasis":[3,43,179],"is":[4,354,365,389,432,515,542,832,938,1245,1256,1317,1365],"a":[5,76,84,167,256,302,312,361,435,442,507,527,622,682,760,768,778,864,926,966,1132,1280,1294,1390,1432,1459,1584,1595,1609,1625,1640,1645,1689,1718],"frequent":[6],"and":[7,53,75,152,157,170,208,261,395,398,421,437,454,462,471,496,498,513,533,552,560,583,604,626,641,651,666,706,719,809,820,829,853,873,877,882,949,1015,1046,1077,1203,1225,1307,1324,1354,1417,1419,1441,1549,1603,1651,1715],"dreaded":[8],"complication":[9],"of":[10,23,67,70,97,110,121,123,140,155,166,186,204,277,284,363,408,444,468,481,493,503,530,554,616,639,647,660,674,694,698,701,715,722,773,780,818,837,846,849,856,890,902,941,944,963,1005,1010,1018,1039,1066,1093,1105,1328,1333,1343,1425,1456,1464,1467,1558,1565,1587,1592,1597,1612,1614,1622,1635,1648,1655,1727],"breast":[11,41,71,90,128,134,150,177,190,205,246,295,317,377,409],"cancer,":[12,129],"with":[13,48,148,259,281,329,372,690,931,974,1131,1177,1222,1262,1277,1302,1356,1411,1452,1571,1608,1624,1632,1688,1703,1735],"obstacles":[14],"such":[15,1413,1499,1539,1659],"as":[16,348,423,425,1165,1293,1414,1500,1540,1660],"the":[17,21,45,68,95,98,104,108,124,141,164,172,227,268,282,299,305,323,349,357,393,406,430,479,550,572,598,645,658,661,675,691,702,712,731,771,816,844,868,888,900,942,961,1003,1040,1043,1049,1074,1081,1094,1103,1119,1135,1143,1148,1248,1285,1320,1325,1340,1357,1383,1395,1487,1501,1513,1552,1556,1566,1617,1716,1725],"blood-brain":[18],"barrier":[19],"impeding":[20],"success":[22],"many":[24],"systemic":[25,1025,1220],"therapies":[26,1228],"in":[27,36,39,94,114,127,132,189,272,298,322,356,369,417,426,558,571,630,634,649,687,711,726,744,751,789,811,840,843,875,880,912,915,965,1042,1048,1073,1080,1102,1113,1129,1142,1147,1160,1191,1232,1260,1300,1370,1376,1382,1458,1476,1569],"this":[28,334,399,555,781,861,957,1085,1152,1194,1216],"setting.":[29],"While":[30,301,540],"there":[31,1168],"has":[32],"been":[33,487],"modest":[34],"progress":[35],"recent":[37,59,568],"years":[38,1202],"treating":[40],"cancer":[42,72,91,178,191,206,247,296,318,378,410,427,514,1520],"to":[44,161,180,243,311,379,465,489,655,657,709,733,785,791,815,897,929,959,972,990,1064,1111,1122,1181,1186,1208,1238,1252,1367,1454,1486,1533,1676,1681,1696,1699],"brain,":[46],"particularly":[47],"stereotactic":[49,984],"radiosurgery,":[50,985],"challenges":[51],"remain":[52],"mortality":[54],"remains":[55,564],"relatively":[56],"high.":[57],"Some":[58],"reports":[60],"have":[61,486,895,1229],"shed":[62],"light":[63],"on":[64,101,176,294,391,597,1509],"unique":[65],"aspects":[66,492],"biology":[69],"brain":[73,192,237,285,324,374,411,585,909,933,1290],"metastases,":[74,1006],"new":[77,403,884],"report":[78],"from":[79,194,236,376,383,749,977,1197,1212,1265,1535],"Zeng":[80],"et":[81,954,1337],"al.":[82],"provides":[83],"potentially":[85,1734],"key":[86,491,672,699,782,869],"insight":[87,293],"into":[88,1242,1431],"how":[89,1237],"may":[92,342,802,1308,1667,1730,1741],"thrive":[93],"milieu":[96],"brain.1":[99],"Building":[100],"prior":[102,313,1187],"studies,":[103],"authors":[105,173,228,269,306,732,1120,1553,1663,1722],"initially":[106],"assessed":[107,229],"expression":[109,120,139,276,620,742,855,1400,1465,1475,1527,1628,1634,1642,1693,1706,1713],"glutamate":[111,216,235,340],"receptor":[112,126,143,169,217,351],"components":[113,122],"human":[115],"cancers.":[116,135],"They":[117,182,239],"noted":[118,183],"high":[119,138,153,184,528,1626,1690],"NMDA":[125,142,187,215,339,350],"most":[130,418,1446],"notably":[131],"basal-like":[133],"In":[136,196,266,359,1116],"particular,":[137],"component":[144,1449],"GRIN2B":[145,278],"was":[146,158,279,653,1030,1070,1086,1099,1139,1153,1169,1175,1379,1450,1630],"associated":[147,280,1176,1410,1631,1687],"triple-negative":[149],"cancers":[151],"risk":[154],"recurrence":[156],"also":[159,270,343,643,1022,1087],"linked":[160],"metastasis.":[162,286,412],"Given":[163],"connection":[165],"neurotransmitter":[168],"metastasis,":[171,1134],"then":[174],"focused":[175],"brain.":[181,300],"activation":[185],"receptors":[188,341],"metastases":[193,375,934],"patients.":[195,921,1235],"mouse":[197,273],"models,":[198],"they":[199,231],"derived":[200],"highly":[201],"brain-metastatic":[202],"versions":[203],"lines":[207,212,221],"showed":[209,271],"that":[210,245,275,316,333,457,544,577,613,671,735,746,766,799,1254,1364,1555,1580,1665,1673,1724,1739],"these":[211,220,482,919,1240,1329,1531,1666],"had":[213,1389],"higher":[214,1633,1646,1653],"activity.":[218],"As":[219],"did":[222],"not":[223,521,633,1088,1257],"produce":[224],"more":[225,1178,1471,1483,1561,1573,1598],"glutamate,":[226],"whether":[230],"might":[232],"be":[233,1309,1368],"getting":[234],"synapses.":[238],"were":[240,249,988,1206,1351,1429,1506],"indeed":[241],"able":[242],"demonstrate":[244],"cells":[248,297,319,420,538,546,563,1350,1362,1397,1521,1582,1593,1623,1650],"intimately":[250],"involved":[251],"at":[252],"glutamatergic":[253],"synapses,":[254],"forming":[255,326],"pseudo-tripartite":[257],"synapse":[258],"presynaptic":[260],"postsynaptic":[262],"neurons\u2014essentially":[263],"replacing":[264],"astrocytes.":[265],"addition,":[267],"models":[274,725],"extent":[283,551],"These":[287,668,728,1428],"results":[288,729,1241,1249],"provide":[289,344,402,1742],"an":[290,627,913,945,1303,1669,1677,1710,1743],"intriguing":[291],"biologic":[292,394],"novel":[303,787,865],"finding,":[304],"do":[307,1250],"note":[308],"its":[309],"complementarity":[310],"study":[314,611,862],"showing":[315],"are":[320,415,499,520,547,594,678,747,1270],"supported":[321],"by":[325,434,813,827,1155,1272,1398],"gap":[327],"junctions":[328],"astrocytes.2":[330],"The":[331,610,1027,1061,1349,1372,1386,1445,1518,1662,1721],"fact":[332],"newly":[335],"described":[336],"phenomenon":[337],"involves":[338],"near-term":[345],"therapeutic":[346,396,885,1746],"leverage,":[347],"inhibitor":[352,1497],"memantine":[353,364],"already":[355,366],"clinic.":[358],"fact,":[360],"course":[362,1306],"being":[367],"used":[368],"some":[370],"patients":[371,930,973,987,1041,1130,1161,1205,1211,1261],"numerous":[373],"alleviate":[380],"side":[381],"effects":[382],"whole-brain":[384,903],"radiation":[385,904],"therapy.":[386,1026],"Additional":[387],"follow-up":[388],"warranted":[390],"both":[392],"fronts,":[397],"will":[400],"hopefully":[401],"traction":[404],"against":[405],"scourge":[407],"Circadian":[413],"clocks":[414],"observed":[416],"normal":[419,584,752,1550,1682],"tissues":[422],"well":[424,516,522],"cells.":[428,637,754,1385,1427],"Molecularly,":[429],"clock":[431,469,484,600,737],"controlled":[433],"transcriptional":[436,463,685],"translational":[438],"feedback":[439],"circuitry":[440],"involving":[441],"set":[443],"\u201cclock":[445],"genes\u201d":[446],"including,":[447],"among":[448],"others,":[449],"Clock,":[450],"Bmal1,":[451],"Periods":[452],"(Per1/2/3),":[453],"Cryptochromes":[455],"(Cry1/2)":[456],"code":[458],"for":[459,606,680,867,887,907,918,951,1359,1435,1438,1443,1493,1503,1745],"transcription":[460,601,1657],"factors":[461,1001,1658,1738],"regulators":[464,502,700],"generate":[466],"rhythms":[467],"gene":[470,473,741,825,1474,1489,1692],"clock-controlled":[472],"expression.":[474],"Through":[475],"their":[476,1273,1399,1572],"rhythmic":[477],"transcription,":[478],"actions":[480],"circadian":[483,511,556,590,676,774,783,870],"genes":[485,1484],"shown":[488,654,1230],"regulate":[490,740,804],"cellular":[494,504,531,1341,1737],"metabolism":[495],"respiration":[497],"considered":[500],"important":[501],"division.":[505],"Although":[506],"robust":[508,589],"link":[509],"between":[510],"dysfunction":[512],"established,":[517],"mechanistic":[518],"details":[519],"understood.":[523],"Glioblastoma":[524],"(GBM)":[525],"displays":[526],"level":[529],"heterogeneity":[532,1323],"contains":[534],"self-renewing":[535],"glioblastoma":[536],"stem":[537,683,753,857],"(GSCs).":[539],"it":[541],"known":[543,1282,1318,1366],"GBM":[545,562,581,636],"intrinsically":[548],"circadian,":[549],"function":[553,769],"rhythmicity":[557],"GSCs":[559,593,631,688,745,790,812,841,881],"differentiated":[561,580,635],"mostly":[565],"unaddressed.":[566],"A":[567,1590,1620],"study,":[569],"published":[570],"journal":[573],"Cancer":[574],"Discovery,1":[575],"demonstrates":[576],"although":[578,1247],"GSCs,":[579,650,716],"cells,":[582,1440,1457,1511],"cultures":[586],"all":[587],"displayed":[588],"rhythms,":[591],"only":[592,1279],"exquisitely":[595],"dependent":[596],"core":[599,736],"factors,":[602],"BMAL1":[603,652,756,762,872],"CLOCK,":[605],"optimal":[607],"cell":[608,623,684,851,1525,1671,1701,1732],"growth.":[609],"established":[612,670],"genetic":[614,1275],"ablation":[615],"Bmal1":[617,640,828],"or":[618,983,995,1008,1108,1545,1616],"Clock":[619,642,830],"induces":[621],"cycle":[624,822],"arrest":[625],"apoptotic":[628],"response":[629],"but":[632,776,1084,1151],"Disruption":[638],"reduced":[644],"maintenance":[646],"stemness":[648,662,879],"bind":[656],"promoters":[659,817],"factor":[663],"SOX2,":[664],"OLIG2,":[665,1415],"MYC.":[667],"studies":[669],"members":[673],"machinery":[677,704],"essential":[679],"maintaining":[681,878],"profile":[686,765],"along":[689],"self-renewal":[692,713],"properties":[693,714],"GSCs.":[695],"Pharmacological":[696],"inhibition":[697],"BMAL1:CLOCK":[703,800],"REV-ERBs":[705],"CRY":[707],"led":[708,730],"disruption":[710,831],"increased":[717],"apoptosis,":[718,847],"prolonged":[720,1217],"survival":[721,947],"GSC":[723,850],"xenograft":[724],"vivo.":[727],"suggest":[734,798],"proteins":[738,871],"likely":[739,1091],"programs":[743],"distinct":[748],"those":[750,1156,1534,1564],"Indeed,":[755],"ChIP-seq":[757],"experiments":[758],"revealed":[759,1470,1579],"GSC-specific":[761],"binding":[763,814],"site":[764],"suggests":[767],"beyond":[770],"generation":[772],"oscillations":[775],"rather":[777],"repurposing":[779],"regulator":[784],"gain":[786],"functions":[788],"support":[792],"aberrant":[793],"tumor":[794,1405,1460,1472,1510],"metabolism.":[795],"Metabolic":[796],"analyses":[797,1578],"heterodimers":[801],"directly":[803],"mitochondrial":[805],"oxidative":[806],"phosphorylation":[807],"(OXPHOS)":[808],"glycolysis":[810,819],"TCA":[821],"genes.":[823],"One":[824],"affected":[826],"succinate":[833],"dehydrogenase":[834],"(SDHA).":[835],"Reduction":[836],"SDHA":[838],"levels":[839,1654],"resulted":[842],"induction":[845],"reduction":[848],"growth,":[852],"decreased":[854],"markers.":[858],"Taken":[859],"together,":[860],"reveals":[863],"role":[866,901,962],"CLOCK":[874],"promoting":[876],"offers":[883],"approaches":[886],"treatment":[889,981],"GBM.":[891],"Several":[892],"clinical":[893,1243,1305,1575],"trials":[894,1188],"tried":[896,1121],"tease":[898],"out":[899],"therapy":[905,1221],"(WBRT)":[906],"metastatic":[908],"tumors,":[910,1478],"resulting":[911],"evolution":[914],"management":[916],"overtime":[917],"challenging":[920],"Most":[922],"experts":[923],"now":[924],"favor":[925],"tailored":[927],"approach":[928],"<4":[932,1263],"(BM).":[935],"Often":[936],"WBRT":[937,964,991,1044,1075,1144,1174,1255],"avoided":[939],"because":[940,1092],"lack":[943],"overall":[946],"benefit":[948],"concern":[950],"neurotoxicity.":[952],"Hong":[953],"al":[955],"continue":[956],"effort":[958],"evaluate":[960],"randomized,":[967],"phase":[968],"III":[969],"trial":[970,1195],"restricted":[971],"1\u20133":[975],"BM":[976,1192,1234,1264],"melanoma.1":[978],"Following":[979],"local":[980,1166],"(surgery":[982],"SRS),":[986],"randomized":[989],"(N":[992,997],"=":[993,998],"107)":[994],"observation":[996,1050,1082,1149],"108).":[999],"Stratification":[1000],"included":[1002],"number":[1004],"presence":[1007],"absence":[1009],"extracranial":[1011],"disease,":[1012],"gender,":[1013],"age,":[1014],"planned":[1016],"dose":[1017],"WBRT.":[1019],"Patients":[1020],"could":[1021],"receive":[1023],"any":[1024],"primary":[1028],"endpoint":[1029],"distant":[1031,1053,1067],"intracranial":[1032,1068,1136],"failure":[1033,1054,1069,1137],"within":[1034,1055],"12":[1035,1056],"months.":[1036],"Forty-two":[1037],"percent":[1038],"cohort":[1045],"50.5%":[1047],"group":[1051,1076,1145],"developed":[1052],"months":[1057,1072,1079],"(not":[1058],"statistically":[1059,1089],"significant).":[1060],"median":[1062,1109],"time":[1063,1110],"development":[1065],"26.4":[1071],"11.5":[1078],"group,":[1083,1150],"significant,":[1090],"small":[1095],"sample":[1096],"size.":[1097],"There":[1098],"no":[1100,1170],"difference":[1101],"rate":[1104,1138],"neurologic":[1106],"death":[1107],"deterioration":[1112],"performance":[1114],"status.":[1115],"several":[1117],"subanalyses,":[1118],"identify":[1123],"subgroups":[1124],"who":[1125,1157,1162],"benefited.":[1126],"For":[1127],"example,":[1128],"single":[1133,1281,1396],"significantly":[1140],"lower":[1141],"than":[1146,1563],"driven":[1154],"received":[1158,1163],"surgery;":[1159],"SRS":[1164],"therapy,":[1167],"difference.":[1171],"Not":[1172],"unexpectedly,":[1173],"grade":[1179,1296],"1":[1180],"2":[1182],"acute":[1183],"toxicity.":[1184],"Similar":[1185],"evaluating":[1189],"RT":[1190],"patients,":[1193],"suffered":[1196],"slow":[1198],"accrual\u2014it":[1199],"took":[1200],"8":[1201],"935":[1204],"screened":[1207],"enroll":[1209],"215":[1210],"24":[1213],"centers.":[1214],"During":[1215],"accrual":[1218],"period,":[1219],"checkpoint":[1223,1496],"inhibitors":[1224],"BRAF":[1226,1286,1392,1636,1685],"targeting":[1227],"responses":[1231],"melanoma":[1233],"Thus,":[1236],"incorporate":[1239],"practice":[1244],"challenging,":[1246],"seem":[1251],"confirm":[1253],"clearly":[1258],"needed":[1259],"melanoma.":[1266],"Pilocytic":[1267],"astrocytomas":[1268],"(PAs)":[1269],"characterized":[1271,1339],"simple":[1274],"make-up":[1276],"usually":[1278],"driver":[1283],"mutation,":[1284],"rearrangement.":[1287],"This":[1288],"pediatric":[1289,1537],"tumor,":[1291],"classified":[1292],"WHO":[1295],"I":[1297],"glioma,":[1298,1538],"presents":[1299],"general":[1301],"indolent":[1304,1574],"cured":[1310],"upon":[1311],"complete":[1312],"surgical":[1313],"resection.":[1314],"However,":[1315],"little":[1316],"about":[1319],"intra-tumoral":[1321],"molecular":[1322],"hierarchic":[1326],"organization":[1327],"tumors.":[1330],"Taking":[1331],"advantage":[1332],"single-cell":[1334],"technology":[1335],"Reitman":[1336],"al1":[1338],"composition":[1342],"6":[1344],"PAs":[1345,1412,1559],"using":[1346],"RNA":[1347],"sequencing.":[1348],"first":[1352],"labeled":[1353],"sorted":[1355],"marker":[1358],"glial":[1360,1408],"progenitor":[1361],"A2B5+":[1363,1384,1404],"enriched":[1369,1434],"PA.":[1371],"KIAA1549-BRAF":[1373],"fusion,":[1374],"detected":[1375],"5/6":[1377],"PAs,":[1378],"exclusively":[1380],"found":[1381],"6th":[1387],"PA":[1388,1519,1581],"non-canonical":[1391],"duplication.":[1393],"Clustering":[1394],"profiles":[1401,1466,1557],"yielded":[1402],"two":[1403,1700],"clusters":[1406,1422],"expressing":[1407,1423],"markers":[1409,1424],"APOD,":[1416],"PDGFRA,":[1418],"three":[1420],"A2B5-":[1421],"immune":[1426,1495],"subdivided":[1430],"cluster":[1433],"microglia,":[1436],"one":[1437,1442,1615,1708],"T":[1439],"macrophages.":[1444],"common":[1447],"non\u2013tumor":[1448],"microglia":[1451,1488],"up":[1453],"40%":[1455],"location-specific":[1461],"manner.":[1462],"Deconvolution":[1463],"bulk":[1468],"tumors":[1469,1481,1548],"cell-related":[1473],"infratentorial":[1477],"whereas":[1479,1512],"supratentorial":[1480],"expressed":[1482,1508,1652],"related":[1485],"cluster.":[1490],"Markers":[1491],"relevant":[1492],"current":[1494],"therapies,":[1498],"ligands":[1502],"PD1":[1504],"CTL4,":[1505],"rarely":[1507],"antigen-presenting":[1514],"capacity":[1515],"appeared":[1516],"intact.":[1517],"exerted":[1522],"oligodendrocyte":[1523],"precursor":[1524],"(OPC)-related":[1526],"signatures.":[1528,1589],"When":[1529],"comparing":[1530],"signatures":[1532,1602],"higher-grade":[1536,1567],"H3K27M":[1541],"mutated":[1542],"midline":[1543],"gliomas":[1544],"IDH":[1546],"mutant":[1547],"OPCs,":[1551],"concluded":[1554],"seemed":[1560,1695],"committed":[1562],"gliomas,":[1568],"line":[1570],"course.":[1576],"Unsupervised":[1577],"express":[1583,1594],"wide":[1585,1610],"spectrum":[1586],"developmental":[1588],"majority":[1591],"mixture":[1596],"mature":[1599],"astrocyte-like":[1600],"(AC-like)":[1601],"less":[1604],"MAPK":[1605,1627,1641,1691,1728],"pathway":[1606],"signaling,":[1607],"range":[1611],"proportions":[1613],"other":[1618,1717,1736],"signature.":[1619],"minority":[1621],"program":[1629,1643,1694],"transcripts.":[1637],"Cells":[1638],"displaying":[1639],"comprised":[1644],"proportion":[1647],"cycling":[1649],"progenitor-associated":[1656],"SOX2.":[1661],"hypothesized":[1664],"reflect":[1668],"OPC-like":[1670],"population":[1672],"gives":[1674],"rise":[1675,1698],"AC-like":[1678],"population,":[1679],"similar":[1680],"development.":[1683],"Activated":[1684],"signaling":[1686,1729],"give":[1697],"populations":[1702],"mutually":[1704],"exclusive":[1705],"programs:":[1707],"exerting":[1709],"oncogene-induced":[1711],"senescence":[1712],"phenotype":[1714],"proliferative":[1719],"phenotype.":[1720],"speculate":[1723],"dosage":[1726],"dictate":[1731],"fate,":[1733],"together":[1740],"opportunity":[1744],"intervention.":[1747]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}